Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report

Saved in:
Bibliographic Details
Published in:IJU Case Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1870297298147213312
collection WordPress RSS
FRELIP Feed Integration
container_title IJU Case Reports
description
discipline_display Urology, Nephrology and Andrology
discipline_facet Urology, Nephrology and Andrology
format Online Article
RSS Article
genre Journal Article
id rss_article:101325
institution FRELIP
journal_source_facet IJU Case Reports
last_indexed 2026-07-10T03:34:57.227Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
sub_discipline_display General
sub_discipline_facet General
subject_display Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
subject_facet Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
title Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
title_alt Deficiencia adquirida de factor XIII autoinmune como un nuevo evento adverso relacionado con la inmunoterapia combinada de ipilimumab y nivolumab para carcinoma de células renales: Reporte de caso
Déficit acquis en facteur XIII auto-immun comme nouvel événement indésirable lié à l'immunité d'un traitement combiné par ipilimumab et nivolumab pour le carcinome rénal : rapport de cas
Deficiência Adquirida Autoimune do Fator XIII como um Novo Evento Adverso Relacionado à Imunidade da Terapia Combinada de Ipilimumabe e Nivolumabe para Carcinoma de Células Renais: Relato de Caso
title_auth Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
title_es_txt Deficiencia adquirida de factor XIII autoinmune como un nuevo evento adverso relacionado con la inmunoterapia combinada de ipilimumab y nivolumab para carcinoma de células renales: Reporte de caso
title_fr_txt Déficit acquis en facteur XIII auto-immun comme nouvel événement indésirable lié à l'immunité d'un traitement combiné par ipilimumab et nivolumab pour le carcinome rénal : rapport de cas
title_full Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
title_fullStr Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
title_full_unstemmed Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
title_pt_txt Deficiência Adquirida Autoimune do Fator XIII como um Novo Evento Adverso Relacionado à Imunidade da Terapia Combinada de Ipilimumabe e Nivolumabe para Carcinoma de Células Renais: Relato de Caso
title_short Acquired Autoimmune Factor XIII Deficiency as a Novel Immune‐Related Adverse Event of Combined Ipilimumab and Nivolumab Therapy for Renal Cell Carcinoma: A Case Report
title_sort acquired autoimmune factor xiii deficiency as a novel immune‐related adverse event of combined ipilimumab and nivolumab therapy for renal cell carcinoma: a case report
topic Urology, Nephrology and Andrology
General
Urology, Nephrology and Andrology
url https://onlinelibrary.wiley.com/doi/10.1002/iju5.70207?af=R